Wisdomtree Trust High Dividend Fund Newsroom

Nvidia, Amazon, Tesla, Palantir Among Top Beneficiaries Of $1 Trillion Saudi Arabia AI Push, Analyst Says

Benzinga17:48 ET

Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030

Benzinga15:58 ET

Shares of Pharmaceutical Stocks Are Trading Lower. The Sector May Down on Continued Weakness Amid President Trump's Drug Pricing Executive Order.

Benzinga15:27 ET

CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up

Benzinga15:26 ET

Decoding IBM's Options Activity: What's the Big Picture?

Benzinga13:02 ET

Expert Outlook: AbbVie Through The Eyes Of 10 Analysts

BenzingaMay 14 09:01 ET

AbbVie Analyst Ratings

BenzingaMay 14 08:18 ET · Ratings

Trump Unveils 'Historic And Transformative' $600 Billion Saudi Deal, Predicts Markets Will 'Go a Lot Higher'

BenzingaMay 13 19:44 ET

A Look Into AbbVie Inc's Price Over Earnings

BenzingaMay 13 15:00 ET

13 Analysts Have This To Say About Johnson & Johnson

BenzingaMay 13 14:01 ET

World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know

BenzingaMay 13 13:27 ET

Peering Into Johnson & Johnson's Recent Short Interest

BenzingaMay 13 13:00 ET

Johnson & Johnson Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $169 to $153.

BenzingaMay 13 12:46 ET

What Does the Market Think About AbbVie?

BenzingaMay 13 11:00 ET

Exxon Mobil Analyst Ratings

BenzingaMay 13 10:13 ET · Ratings

Johnson & Johnson Analyst Ratings

BenzingaMay 13 10:08 ET · Ratings

Chevron Analyst Ratings

BenzingaMay 13 09:56 ET · Ratings

AST SpaceMobile Sets $75 Million Target For 2025 As CFO Andrew Johnson Says 'Revenue Is Ramping On Plan' Amid Surging Demand For Direct-To-Device Satellite Connectivity

BenzingaMay 13 04:10 ET

"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".

① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.

cls.cnMay 12 20:52 ET

U.S. stock market close: The Nasdaq surged over 4%, Chinese concept stocks performed even stronger, and the Golden Dragon Index outperformed the Large Cap.

① High-level economic and trade talks between China and the U.S. exceeded expectations, boosting U.S. stocks; ② Both the S&P and Nasdaq hit new closing highs since March 3; ③ NVIDIA rose over 5%, with its Market Cap returning to above 3 trillion; ④ Trump: Will investigate pharmaceutical companies if necessary.

cls.cnMay 12 17:45 ET